Sepideh Saroukhani, MD, MS, PhD student
Cited by
Cited by
Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial
A Modabbernia, H Sohrabi, AA Nasehi, F Raisi, S Saroukhani, A Jamshidi, ...
Psychopharmacology 223 (4), 381-388, 2012
Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study
L Kashani, F Raisi, S Saroukhani, H Sohrabi, A Modabbernia, AA Nasehi, ...
Human Psychopharmacology: Clinical and Experimental 28 (1), 54-60, 2013
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous …
N Shahmansouri, M Farokhnia, SH Abbasi, SE Kassaian, AAN Tafti, ...
Journal of Affective disorders 155, 216-222, 2014
The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats
M Nassiri-Asl, SR Mortazavi, F Samiee-Rad, AA Zangivand, F Safdari, ...
Epilepsy & Behavior 18 (1-2), 50-53, 2010
Aspirin for treatment of lithium‐associated sexual dysfunction in men: randomized double‐blind placebo‐controlled study
S Saroukhani, M Emami‐Parsa, A Modabbernia, M Ashrafi, M Farokhnia, ...
Bipolar disorders 15 (6), 650-656, 2013
Health-related quality of life in primary antibody deficiency
A Aghamohammadi, A Montazeri, H Abolhassani, S Saroukhani, ...
Iranian Journal of Allergy, Asthma and Immunology, 47-51, 2011
Anticonvulsant effects of aqueous extract of Glycyrrhiza glabra root in PTZ-induced seizure in mice
M Nassiri-Asl, S Saroukhani, F Zamansoltani
Int J Pharmacol 3, 432-434, 2007
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome
M Salarifar, MR Mousavi, S Saroukhani, E Nematipour, SE Kassaian, ...
Texas Heart Institute Journal 41 (1), 40-47, 2014
A randomized, double-blind, placebo-controlled study of safety of the adjunctive saffron on sexual dysfunction induced by a selective serotonin reuptake inhibitor
P Mansoori, S Akhondzadeh, F Raisi, P Ghaeli, AH Jamshidi, AA Nasehi, ...
Journal of Medicinal Plants 10 (37), 121-130, 2011
Major adverse events, six months after endovascular revascularization for critical limb ischemia in diabetic patients
SE Kassaian, M Mohajeri-Tehrani, A Dehghan-Nayyeri, S Saroukhani, ...
Archives of Iranian Medicine 16 (5), 0-0, 2013
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
Y Nozari, S Vosooghi, M Boroumand, H Poorhosseini, E Nematipour, ...
Anatolian journal of cardiology 15 (5), 348, 2015
Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies
S Saroukhani, A Aghamohammadi, J Mahmoudi‐Gharaei, H Abolhassani, ...
Human Psychopharmacology: Clinical and Experimental 25 (5), 419-422, 2010
One-year clinical outcomes of ultra long Apollo polymer-based paclitaxel-eluting stents in patients with complex, long coronary artery lesions
M Salarifar, SE Kassaian, M Alidoosti, AM Haji-Zeinali, HR Poorhoseini, ...
The Journal of Tehran Heart Center 6 (3), 138, 2011
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study
E Parsa, S Saroukhani, F Majlessi, H Poorhosseini, M Lofti-Tokaldany, ...
Texas Heart Institute Journal 43 (2), 126-130, 2016
A risk-scoring model to predict one-year major adverse cardiac events after percutaneous coronary intervention
SE Kassaian, S Saroukhani, F Alaeddini, M Salarifar, D Capodanno, ...
The Journal of Tehran University Heart Center 10 (4), 167, 2015
Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in …
M Alidoosti, S Saroukhani, M Lotfi-Tokaldany, A Jalali, ...
Cardiovascular Revascularization Medicine 17 (5), 308-312, 2016
Evaluation of in-hospital NT-proBNP changes in heart failure patients to identify the six-month clinical response following cardiac resynchronization therapy.
G Davoodi, A Bagheri, A Yamini-Sharif, M Boroumand, S Saroukhani, ...
Acta Medica Iranica, 15-23, 2014
Retrograde Trans-Femoral Approach for Successful Per-cutaneous Angioplasty in a Diabetic Patient with Ischemic Hand Ulcer: A Case Report
Z Annabestani, SE Kassaian, MR Mohajeri-Tehrani, S Mohseni, ...
The Journal of Tehran University Heart Center 8 (4), 205-209, 2013
Comparison of 1-year major adverse cardiac events in patients undergoing primary percutaneous coronary intervention receiving intracoronary bolus only versus intracoronary …
SE Kassaian, Y Fathi, M Lotfi-Tokaldany, M Salarifar, M Alidoosti, ...
Critical pathways in cardiology 15 (3), 89-94, 2016
Comparing clinical outcomes for a twelve-month trial of zotarolimus-and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry
HR Poorhoseini, SE Kassaian, K Hoseini, S Saroukhani, M Salarifar, ...
Therapeutic advances in cardiovascular disease 10 (4), 206-213, 2016
The system can't perform the operation now. Try again later.
Articles 1–20